178 related articles for article (PubMed ID: 19463055)
21. Evaluation of the mode of action and human relevance of liver tumors in male mice treated with epyrifenacil.
Fukunaga S; Ogata K; Eguchi A; Matsunaga K; Sakurai K; Abe J; Cohen SM; Asano H
Regul Toxicol Pharmacol; 2022 Dec; 136():105268. PubMed ID: 36210011
[TBL] [Abstract][Full Text] [Related]
22. [Peroxisome proliferation and possible cancer hazard].
Dybing E; Sanner T
Tidsskr Nor Laegeforen; 1995 Jun; 115(15):1839-41. PubMed ID: 7638833
[TBL] [Abstract][Full Text] [Related]
23. Case study: an evaluation of the human relevance of the synthetic pyrethroid metofluthrin-induced liver tumors in rats based on mode of action.
Yamada T; Uwagawa S; Okuno Y; Cohen SM; Kaneko H
Toxicol Sci; 2009 Mar; 108(1):59-68. PubMed ID: 19176367
[TBL] [Abstract][Full Text] [Related]
24. Cyproterone acetate: a genotoxic carcinogen?
Kasper P
Pharmacol Toxicol; 2001 May; 88(5):223-31. PubMed ID: 11393581
[TBL] [Abstract][Full Text] [Related]
25. Carcinogenic mode of action of folpet in mice and evaluation of its relevance to humans.
Cohen SM; Gordon EB; Singh P; Arce GT; Nyska A
Crit Rev Toxicol; 2010 Jul; 40(6):531-45. PubMed ID: 20521864
[TBL] [Abstract][Full Text] [Related]
26. An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide.
McCarroll N; Keshava N; Cimino M; Chu M; Dearfield K; Keshava C; Kligerman A; Owen R; Protzel A; Putzrath R; Schoeny R
Environ Mol Mutagen; 2008 Mar; 49(2):117-31. PubMed ID: 18240158
[TBL] [Abstract][Full Text] [Related]
27. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
28. An Evaluation of the Human Relevance of the Liver Tumors Observed in Female Mice Treated With Permethrin Based on Mode of Action.
Kondo M; Kikumoto H; Osimitz TG; Cohen SM; Lake BG; Yamada T
Toxicol Sci; 2020 May; 175(1):50-63. PubMed ID: 32040184
[TBL] [Abstract][Full Text] [Related]
29. Effects of rat strain, diet composition, and phenobarbital on hepatic gamma-glutamyl transpeptidase histochemistry and on the induction of altered hepatocyte foci and hepatic tumors by diethylnitrosamine.
Russell JJ; Staffeldt EF; Wright BJ; Prapuolenis A; Carnes BA; Peraino C
Cancer Res; 1987 Feb; 47(4):1130-4. PubMed ID: 2879625
[TBL] [Abstract][Full Text] [Related]
30. Mode of action analysis for the synthetic pyrethroid metofluthrin-induced rat liver tumors: evidence for hepatic CYP2B induction and hepatocyte proliferation.
Deguchi Y; Yamada T; Hirose Y; Nagahori H; Kushida M; Sumida K; Sukata T; Tomigahara Y; Nishioka K; Uwagawa S; Kawamura S; Okuno Y
Toxicol Sci; 2009 Mar; 108(1):69-80. PubMed ID: 19176366
[TBL] [Abstract][Full Text] [Related]
31. Carcinogenicity and mode of action evaluation for alpha-hexachlorocyclohexane: Implications for human health risk assessment.
Bradley AE; Shoenfelt JL; Durda JL
Regul Toxicol Pharmacol; 2016 Apr; 76():152-73. PubMed ID: 26713892
[TBL] [Abstract][Full Text] [Related]
32. Critical evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR).
Yamada T; Cohen SM; Lake BG
Crit Rev Toxicol; 2021 May; 51(5):373-394. PubMed ID: 34264181
[TBL] [Abstract][Full Text] [Related]
33. IPCS framework for analyzing the relevance of a cancer mode of action for humans.
Boobis AR; Cohen SM; Dellarco V; McGregor D; Meek ME; Vickers C; Willcocks D; Farland W
Crit Rev Toxicol; 2006; 36(10):781-92. PubMed ID: 17118728
[TBL] [Abstract][Full Text] [Related]
34. Tamoxifen induces short-term cumulative DNA damage and liver tumors in rats: promotion by phenobarbital.
Carthew P; Martin EA; White IN; De Matteis F; Edwards RE; Dorman BM; Heydon RT; Smith LL
Cancer Res; 1995 Feb; 55(3):544-7. PubMed ID: 7834623
[TBL] [Abstract][Full Text] [Related]
35. An adjustment factor for mode-of-action uncertainty with dual-mode carcinogens: the case of naphthalene-induced nasal tumors in rats.
Bogen KT
Risk Anal; 2008 Aug; 28(4):1033-51. PubMed ID: 18564993
[TBL] [Abstract][Full Text] [Related]
36. A mechanism-based cancer risk assessment for 1,4-dichlorobenzene.
Butterworth BE; Aylward LL; Hays SM
Regul Toxicol Pharmacol; 2007 Nov; 49(2):138-48. PubMed ID: 17688981
[TBL] [Abstract][Full Text] [Related]
37. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
38. Review of the carcinogenic activity of diethanolamine and evidence of choline deficiency as a plausible mode of action.
Leung HW; Kamendulis LM; Stott WT
Regul Toxicol Pharmacol; 2005 Dec; 43(3):260-71. PubMed ID: 16188361
[TBL] [Abstract][Full Text] [Related]
39. Aberrant expression of adaptation to phenobarbital may cause selective growth of foci of altered cells in rat liver.
Schulte-Hermann R; Timmermann-Trosiener I; Schuppler J
IARC Sci Publ; 1984; (56):67-75. PubMed ID: 6152623
[TBL] [Abstract][Full Text] [Related]
40. Toxic effects of griseofulvin: disease models, mechanisms, and risk assessment.
Knasmüller S; Parzefall W; Helma C; Kassie F; Ecker S; Schulte-Hermann R
Crit Rev Toxicol; 1997 Sep; 27(5):495-537. PubMed ID: 9347226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
